The Project

Berry Consultants are leading experts in clinical trial simulation with a global market leading clinical trial simulation software, providing services to enable clients to design clinical trials. Prior to the AKT project, the software configuration exploration was performed manually, rather than with a more systematic method.

AKT Associate, Matthew Darlington worked with the team at Berry Consultants, along with Dr Luke Rhodes-Leader in the Department of Management Science at Lancaster University Management School to deliver the AKT project.

The AKT project’s key aim was to investigate the use of simulation optimisation techniques to find optimal trial designs in a more systematic and efficient manner, enabling the company to offer an additional service to their clients beyond an evaluation tool, allowing them to provide consultancy services and software of higher value to the clients, which, in turn would speed up the clinical trial design process and lead to more favourable patient outcomes.

Through the AKT project collaboration, Berry Consultants have accelerated an innovative new system by developing an advanced usable proof of concept and improved processes within the company, along with new IP and revenue stream potential.

As a result of the AKT project, the company has been able to fully document and directly implement the algorithms, enabling them to directly apply to real client cases, as well as being able to adapt to other designs, which were outside the scope of this project and offers potential for further growth.